Skip to content

Precision Versus Endurance Training to Improve Walking After Chronic Incomplete SCI

Precision Versus Endurance Training to Improve Walking After Chronic Incomplete SCI

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01765153
Enrollment
21
Registered
2013-01-10
Start date
2008-03-31
Completion date
2012-09-30
Last updated
2017-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spinal Cord Injury

Keywords

physical therapy, rehabilitation, neuroplasticity

Brief summary

The objective of the study was to determine the efficacy of two forms of physical therapy training, one emphasizing precise, visually guided walking over obstacles and on targets (Precision Training), the other emphasizing mass practice of walking on a treadmill (Endurance Training). The hypothesis was that visually guided training (Precision) may be especially efficacious because it engages the motor cortex, whose input may facilitate improvements in functional walking. Participants are individuals with a chronic (≥7 months post-injury), motor incomplete spinal cord injury (SCI), with no other problems that would preclude participation in an intensive training program. A randomized, single-blinded, cross-over design was used to randomly allocate participants to start with Precision or Endurance Training, identified as Training Phase I. Training was 5x/wk for 2 months, followed by a 2-month rest period, identified as Rest Period I. Participants then returned for 2-months of training in the other method, identified as Training Phase II, followed by another 2-month rest, Rest Period II. Measures of walking speed, distance, skill, confidence, as well as depression were obtained at least 3 times before any training, then monthly thereafter. Electrophysiological measures were taken before and after each phase of training and period of rest. Change scores were used to determine how each phase of training and rest influenced the scores (see below).

Detailed description

PARTICIPANTS: Inclusion criteria: 1) SCI from trauma or other stable lesions, 2) injury occurred ≥ 7 mo prior, 3) able to walk independently at least 5 m with a walking aid and/or braces, 4) injury level between C1-L1, 5) able to give informed consent, 6) able to attend training sessions 5x/week. Exclusion criteria: 1) head injury, 2) cognitive or musculoskeletal impairments that preclude participation in walking training, 3) seizures or implants in the head that would preclude participation in experiments using transcranial magnetic stimulation (TMS). INTERVENTIONS: Precision Training. Training was performed on a 15 m long track. The track contained obstacles and targets. Obstacles were made of Styrofoam blocks of 3 cm height each, varying in width from 4 cm to 20 cm in divisions of 4 cm increments (which must be cleared without touching), and targets were made of fabric circles, ranging in diameter from 7-10.5 cm (which must be totally obscured by their foot). The difficulty of the track was designed to have the participant achieve \ 80% success. The emphasis was on accuracy, not speed. Endurance Training. The aim of this training was mass practice. Participants walked on the treadmill, with body-weight support (BWS) and manual assistance if needed. The treadmill speed was initially set to be faster than their over ground walking speed as measured by the 10 MWT(ss). Participants were encouraged to walk for as far and as fast as possible with minimal rest periods. Progression involved reducing manual assistance and BWS, increasing walking speed and distance, while reducing rest breaks. In both phases of training, a research assistant or volunteer recorded training parameters each session. The number of steps executed was measured with a step counter (StepWatch, Orthocare Innovations, USA), which was confirmed to be accurate with simultaneous manual counting prior to its use, and periodically during training sessions. The heart rate before and immediately after each bout of walking was measured with a heart rate monitor (Polar FT7, Polar, Canada). The total time, distance and walking speed for each walking bout was recorded. MEASURES: Measures were taken prior to all training at baseline (called Baseline I) and the end of each of the following intervals - one month of Training Phase I, two months of Training Phase I, one month of Rest Period I, two months of Rest Period I, one month of Training Phase II, two months of Training Phase II, one month of Rest Period II, two months of Rest Period II. To measure changes during the second phase of training, the baseline was the average of the one and two month measures of Rest Period I, henceforth called Baseline II. STATISTICAL ANALYSIS: To determined if one type of training was superior to the other, we compared the change scores (i.e., post-training score minus pre-training score) from each type of training using a standard t-test or a Mann-Whitney U test, as appropriate. Since individuals with high compared to low walking function may respond to the training differently, we divided individuals based on their pretraining walking speed as measured by the 10 MWT(ss) (i.e., \> or \< 0.5 m/s). The change scores from each of these groups of individuals were then compared for each type of training using a standard t-test or a Mann-Whitney U test, as appropriate. To determine the time course for obtaining a treatment effect, we compared the change scores for the first month (i.e., outcome measure at end of 1 mo minus baseline) versus the second month (outcome measure at end of 2 mo minus at end of 1 mo) of training for each type of training, using a standard t-test or a Mann-Whitney U test, as appropriate. Retention of gains was followed for 2 months after each type of training. The outcome measures at the end of the 2 month rest period were compared to the measures immediately after the training, for individuals that made improvements greater than the standard error of measurement for each measure, using a paired t-test or Wilcoxon signed-rank test, as appropriate.

Interventions

BEHAVIORALEndurance

Participants are trained daily to walk on a treadmill for as fast and as long as possible. A harness supporting part of their body weight can be used if needed. Assistance from a trainer is used if needed. A physical therapist supervises the training.

BEHAVIORALPrecision

Participants train daily to walk over ground on 15 m straight hallway with obstacles they must step over, and targets they must step onto.

Sponsors

Canadian Institutes of Health Research (CIHR)
CollaboratorOTHER_GOV
University of Alberta
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* spinal cord injury equal or more than 7 months prior * able to walk at least 5 meters independently (can use walking aids and braces) * injury level between C1 and L1 * able to give informed consent * able to attend training sessions 5x/week

Exclusion criteria

* head injury * cognitive of musculoskeletal impairments that preclude participation in walking training * seizures or implants in the head that would preclude participation in experiments with transcranial magnetic stimulation

Design outcomes

Primary

MeasureTime frameDescription
Change in Spinal Cord Injury - Functional Ambulation Profile (SCI-FAP) at Completion of StudyChange from Baseline I to the end of the study (i.e., end of Rest Period II, which was ~8 months after the beginning of the study)This is a 7 item, timed walking test. Participants perform each of the walking tasks and the time to complete each task is recorded. Maximum times are set for each task. An assistance category is assigned based on the walking aids used, with 1 being no aid and 6 being unable to complete the task. A score for each item is calculated as: Time x Assistance factor/Mean able bodied time. A composite (single) score is obtained by summing the scores for all 7 items. The maximum score for the scale is 2100 indicating that the participant was unable to complete any of the 7 tasks within the allowed time. A minimum score of 7 indicates that all tasks were performed with no aids and at the mean able-bodied time. Results are reported as a measure of change: Final score - initial score. A negative result indicates improvement.

Secondary

MeasureTime frameDescription
Change in Spinal Cord Injury - Functional Ambulation Profile (SCI-FAP) at the End of 2 Months of Rest Period IChange from the end of Phase I training (measured at 2 months of Training Phase I) to 2 months of Rest Period IThis is a 7 item, timed walking test. Participants perform each of the walking tasks and the time to complete each task is recorded. Maximum times are set for each task. An assistance category is assigned based on the walking aids used, with 1 being no aid and 6 being unable to complete the task. A score for each item is calculated as: Time x Assistance factor/Mean able bodied time. A composite (single) score is obtained by summing the scores for all 7 items. The maximum score for the scale is 2100 indicating that the participant was unable to complete any of the 7 tasks within the allowed time. A minimum score of 7 indicates that all tasks were performed with no aids and at the mean able-bodied time. Results are reported as a measure of change: Final score - initial score. A negative result indicates improvement.
Change in Spinal Cord Injury - Functional Ambulation Profile (SCI-FAP) at 2 Months of Training Phase IIChange from Baseline II to 2 months of Training Phase IIThis is a 7 item, timed walking test. Participants perform each of the walking tasks and the time to complete each task is recorded. Maximum times are set for each task. An assistance category is assigned based on the walking aids used, with 1 being no aid and 6 being unable to complete the task. A score for each item is calculated as: Time x Assistance factor/Mean able bodied time. A composite (single) score is obtained by summing the scores for all 7 items. The maximum score for the scale is 2100 indicating that the participant was unable to complete any of the 7 tasks within the allowed time. A minimum score of 7 indicates that all tasks were performed with no aids and at the mean able-bodied time. Results are reported as a measure of change: Final score - initial score. A negative result indicates improvement.
Change in Spinal Cord Injury - Functional Ambulation Profile (SCI-FAP) at the End of 2 Months of Rest Period IIChange from the end of Phase II training (measured at 2 months of Training Phase II) to 2 months of Rest Period IIThis is a 7 item, timed walking test. Participants perform each of the walking tasks and the time to complete each task is recorded. Maximum times are set for each task. An assistance category is assigned based on the walking aids used, with 1 being no aid and 6 being unable to complete the task. A score for each item is calculated as: Time x Assistance factor/Mean able bodied time. A composite (single) score is obtained by summing the scores for all 7 items. The maximum score for the scale is 2100 indicating that the participant was unable to complete any of the 7 tasks within the allowed time. A minimum score of 7 indicates that all tasks were performed with no aids and at the mean able-bodied time. Results are reported as a measure of change: Final score - initial score. A negative result indicates improvement.
Change in 6 Minute Walk Test (6MWT) at 2 Months of Training Phase IChange from Baseline I to 2 months of Training Phase IParticipants walk for as far as possible in 6 min along a 25m hallway.
Change in 6 Minute Walk Test (6MWT) at the End of 2 Months of Rest Period IChange from the end of Phase I training (measured at 2 months of Training Phase I) to 2 months of Rest Period IParticipants walk for as far as possible in 6 min along a 25m hallway. Total distance walked in the time is measured. Results are calculated as : Distance walked at end of period - Distance walked at beginning of period.
Change in 6 Minute Walk Test (6MWT) at 2 Months of Training Phase IIChange from Baseline II to 2 months of Training Phase IIParticipants walk for as far as possible in 6 min along a 25m hallway. Total distance walked in the time is measured. Results are calculated as : Distance walked at end of period - Distance walked at beginning of period.
Change in 6 Minute Walk Test (6MWT) at the End of 2 Months of Rest Period IIChange from the end of Phase II training to 2 months of Rest Period IIParticipants walk for as far as possible in 6 min along a 25m hallway. Total distance walked in the time is measured. Results are calculated as : Distance walked at end of period - Distance walked at beginning of period.
Change in 10 Metre Walk Test at a Self-selected Speed [10MWT(ss)] at 2 Months of Training Phase IChange from Baseline I to 2 months of Training Phase IParticipants walk along a 14 meter path on a smooth floor at a comfortable pace. The middle 10 m is timed. Speed over 10 m is calculated as 10 m/Time. Results are calculated as: Final speed - initial speed.
Change in 10 Meter Walk Test at a Self-selected Speed [10MWT(ss)] at the End of 2 Months of Rest Period IChange from the end of Phase I training (measured at 2 months of Training Phase I) to 2 months of Rest Period IParticipants walk along a 14 meter path on a smooth floor at a comfortable pace. The middle 10 m is timed. Speed over 10 m is calculated as 10 m/Time. Results are calculated as: Final speed - initial speed.
Change in 10 Meter Walk Test at a Self-selected Speed [10MWT(ss)] at 2 Months of Training Phase IIChange from Baseline II to 2 months of Training Phase IIParticipants walk along a 14 meter path on a smooth floor at a comfortable pace. The middle 10 m is timed. Speed over 10 m is calculated as 10 m/Time. Results are calculated as: Final speed - initial speed.
Change in 10 Meter Walk Test at a Self-selected Speed [10MWT(ss)] at the End of 2 Months of Rest Period IIChange from the end of Phase II training (measured at 2 months of Training Phase II) to 2 months of Rest Period IIParticipants walk along a 14 meter path on a smooth floor at a comfortable pace. The middle 10 m is timed. Speed over 10 m is calculated as 10 m/Time. Results are calculated as: Final speed - initial speed.
Change in 10 Meter Walk Test at a Fast Speed [10MWT(f)] at 2 Months of Training Phase IChange from Baseline I to 2 months of Training Phase IParticipants walk as quickly as they are able to along a 14 meter path on a smooth floor. The middle 10 m is timed. Speed over 10 m is calculated as 10 m/Time. Results are calculated as: Final speed - initial speed.
Change in 10 Meter Walk Test at a Fast Speed [10MWT(f)] at the End of 2 Months of Rest Period IChange from the end of Phase I training (measured at 2 months of Training Phase I) to 2 months of Rest Period IParticipants walk as quickly as they are able to along a 14 meter path on a smooth floor. The middle 10 m is timed. Speed over 10 m is calculated as 10 m/Time. Results are calculated as: Final speed - initial speed.
Change in 10 Meter Walk Test at a Fast Speed [10MWT(f)] at 2 Months of Training Phase IIChange from Baseline II to 2 months of Training Phase IIParticipants walk as quickly as they are able to along a 14 meter path on a smooth floor. The middle 10 m is timed. Speed over 10 m is calculated as 10 m/Time. Results are calculated as: Final speed - initial speed.
Change in 10 Meter Walk Test at a Fast Speed [10MWT(f)] at the End of 2 Months of Rest Period IIChange from the end of Phase II training (measured at 2 months of Training Phase II) to 2 months of Rest Period IIParticipants walk as quickly as they are able to along a 14 meter path on a smooth floor. The middle 10 m is timed. Speed over 10 m is calculated as 10 m/Time. Results are calculated as: Final speed - initial speed.
Change in Walking Index for Spinal Cord Injury Version II Self-selected (WISCI-II ss) at 2 Months of Training Phase IChange from Baseline I to 2 months of Training Phase IParticipants are scored from 0 to 20 based on the walking aid they select to walk a distance of 10 meters. Walking aids and physical assistance provided are ranked on an ordinal scale from 1 to 20. A score of 0 indicates the participant is unable to walk 10 m, 20 indicates no aids are required to complete the task. Results are reported as Final score - Initial score. A positive result indicates that less assistance was required.
Change in Walking Index for Spinal Cord Injury Version II Self-selected (WISCI-II ss) at the End of 2 Months of Rest Period IChange from the end of Phase I training (measured at 2 months of Training Phase I) to 2 months of Rest Period IParticipants are scored from 0 to 20 based on the walking aid they select to walk a distance of 10 meters. Walking aids and physical assistance provided are ranked on an ordinal scale from 1 to 20. A score of 0 indicates the participant is unable to walk 10 m, 20 indicates no aids are required to complete the task. Results are reported as Final score - Initial score. A positive result indicates that less assistance was required.
Change in Walking Index for Spinal Cord Injury Version II Self-selected (WISCI-II ss) at 2 Months of Training Phase IIChange from Baseline II to 2 months of Training Phase IIParticipants are scored from 0 to 20 based on the walking aid they select to walk a distance of 10 meters. Walking aids and physical assistance provided are ranked on an ordinal scale from 1 to 20. A score of 0 indicates the participant is unable to walk 10 m, 20 indicates no aids are required to complete the task. Results are reported as Final score - Initial score. A positive result indicates that less assistance was required.
Change in Walking Index for Spinal Cord Injury Version II Self-selected (WISCI-II ss) at the End of 2 Months of Rest Period IIChange from the end of Phase II training (measured at 2 months of Training Phase II) to 2 months of Rest Period IIParticipants are scored from 0 to 20 based on the walking aid they select to walk a distance of 10 meters. Walking aids and physical assistance provided are ranked on an ordinal scale from 1 to 20. A score of 0 indicates the participant is unable to walk 10 m, 20 indicates no aids are required to complete the task. Results are reported as Final score - Initial score. A positive result indicates that less assistance was required.
Change in Walking Index for Spinal Cord Injury Version II Maximum [WISCI-II (Max)] at 2 Months of Training Phase IChange from Baseline I to 2 months of Training Phase IParticipants are scored from 0 to 20 based on the least amount of assistance/aid they require to walk a distance of 10 meters. Walking aids and physical assistance provided are ranked on an ordinal scale from 1 to 20. A score of 0 indicates the participant is unable to walk 10 m, 20 indicates no aids are required to complete the task. Results are reported as Final score - Initial score. A positive result indicates that less assistance was required.
Change in Walking Index for Spinal Cord Injury Version II Maximum [WISCI-II (Max)] at the End of 2 Months of Rest Period IChange from the end of Phase I training (measured at 2 months of Training Phase I) to 2 months of Rest Period IParticipants are scored from 0 to 20 based on the least amount of assistance/aid they require to walk a distance of 10 meters. Walking aids and physical assistance provided are ranked on an ordinal scale from 1 to 20. A score of 0 indicates the participant is unable to walk 10 m, 20 indicates no aids are required to complete the task. Results are reported as Final score - Initial score. A positive result indicates that less assistance was required.
Change in Walking Index for Spinal Cord Injury Version II Maximum [WISCI-II (Max)] at 2 Months of Training Phase IIChange from Baseline II to 2 months of Training Phase IIParticipants are scored from 0 to 20 based on the least amount of assistance/aid they require to walk a distance of 10 meters. Walking aids and physical assistance provided are ranked on an ordinal scale from 1 to 20. A score of 0 indicates the participant is unable to walk 10 m, 20 indicates no aids are required to complete the task. Results are reported as Final score - Initial score. A positive result indicates that less assistance was required.
Change in Walking Index for Spinal Cord Injury Version II Maximum [WISCI-II (Max)] at the End of 2 Months of Rest Period IIChange from the end of Phase II training (measured at 2 months of Training Phase II) to 2 months of Rest Period IIParticipants are scored from 0 to 20 based on the least amount of assistance/aid they require to walk a distance of 10 meters. Walking aids and physical assistance provided are ranked on an ordinal scale from 1 to 20. A score of 0 indicates the participant is unable to walk 10 m, 20 indicates no aids are required to complete the task. Results are reported as Final score - Initial score. A positive result indicates that less assistance was required.
Change in Activities-specific Balance Confidence Scale (ABC) at 2 Months of Training Phase IChange from Baseline I to 2 months of Training Phase IA survey with 16 questions regarding the participants confidence in their ability to perform specific tasks requiring balance. Participants rate their confidence as a percentage from 0% (no confidence in their ability to perform the task) to 100% 9 completely confident in their ability to complete the task safely. Total score is calculated as: Sum of item scores/16 and is expressed as a percentage. Results are reported as Final score - Initial score. A positive result indicates a higher level of confidence in ability.
Change in Activities-specific Balance Confidence Scale (ABC) at the End of 2 Months of Rest Period IChange from the end of Phase I training (measured at 2 months of Training Phase I) to 2 months of Rest Period IA survey with 16 questions regarding the participants confidence in their ability to perform specific tasks requiring balance. Participants rate their confidence as a percentage from 0% (no confidence in their ability to perform the task) to 100% 9 completely confident in their ability to complete the task safely. Total score is calculated as: Sum of item scores/16 and is expressed as a percentage. Results are reported as Final score - Initial score. A positive result indicates a higher level of confidence in ability.
Change in Activities-specific Balance Confidence Scale (ABC) at 2 Months of Training Phase IIChange from Baseline II to 2 months of Training Phase IIA survey with 16 questions regarding the participants confidence in their ability to perform specific tasks requiring balance. Participants rate their confidence as a percentage from 0% (no confidence in their ability to perform the task) to 100% 9 completely confident in their ability to complete the task safely. Total score is calculated as: Sum of item scores/16 and is expressed as a percentage. Results are reported as Final score - Initial score. A positive result indicates a higher level of confidence in ability.
Change in Activities-specific Balance Confidence Scale (ABC) at the End of 2 Months of Rest Period IIChange from the end of Phase II training (measured at 2 months of Training Phase II) to 2 months of Rest Period IIA survey with 16 questions regarding the participants confidence in their ability to perform specific tasks requiring balance. Participants rate their confidence as a percentage from 0% (no confidence in their ability to perform the task) to 100% 9 completely confident in their ability to complete the task safely. Total score is calculated as: Sum of item scores/16 and is expressed as a percentage. Results are reported as Final score - Initial score. A positive result indicates a higher level of confidence in ability.
Change in Center for Epidemiologic Studies - Depression Scale (CES-D) at 2 Months of Training Phase IChange from Baseline I to 2 months of Training Phase IA 20 question survey to measure current level of depressive symptoms. The participant ranks their emotional state or actions for each question on an ordinal scale of 0 to 3, with 0 indicating rarely or never and 3 being most of the time. A minimum score of 0 indicates no depressive symptoms, and a score of 10 or greater is considered indicative of depression. The max score for the scale is 60. Results are reported as Final score - Initial score. A negative result indicates a lower level of depression.
Change in Center for Epidemiologic Studies - Depression Scale (CES-D) at the End of 2 Months of Rest Period IChange from the end of Phase I training (measured at 2 months of Training Phase I) to 2 months of Rest Period IA 20 question survey to measure current level of depressive symptoms.The participant ranks their emotional state or actions for each question on an ordinal scale of 0 to 3, with 0 indicating rarely or never and 3 being most of the time. A minimum score of 0 indicates no depressive symptoms, and a score of 10 or greater is considered indicative of depression. The max score for the scale is 60. Results are reported as Final score - Initial score. A negative result indicates a lower level of depression.
Change in Center for Epidemiologic Studies - Depression Scale (CES-D) at 2 Months of Training Phase IIChange from Baseline II to 2 months of Training Phase IIA 20 question survey to measure current level of depressive symptoms.The participant ranks their emotional state or actions for each question on an ordinal scale of 0 to 3, with 0 indicating rarely or never and 3 being most of the time. A minimum score of 0 indicates no depressive symptoms, and a score of 10 or greater is considered indicative of depression. The max score for the scale is 60. Results are reported as Final score - Initial score. A negative result indicates a lower level of depression.
Change in Center for Epidemiologic Studies - Depression Scale (CES-D) at the End of 2 Months of Rest Period IIChange from the end of Phase II training (measured at 2 months of Training Phase II) to 2 months of Rest Period IIA 20 question survey to measure current level of depressive symptoms.The participant ranks their emotional state or actions for each question on an ordinal scale of 0 to 3, with 0 indicating rarely or never and 3 being most of the time. A minimum score of 0 indicates no depressive symptoms, and a score of 10 or greater is considered indicative of depression. The max score for the scale is 60. Results are reported as Final score - Initial score. A negative result indicates a lower level of depression.
Change in Manual Muscle Test (MMT) at 2 Months of Training Phase IChange from Baseline I to 2 months of Training Phase IThe strength of each of 8 major muscle groups (per side) in the lower extremities is graded using the standard manual muscle testing technique. Strength is graded from 0 (no muscle activity detected) to 5 (strength with normal range for the muscle group). Scores from all muscle groups are added to obtain the total score. The total score ranges from 0 (unable to produce any muscle activity in all 8 muscle groups bilaterally) to 80 (normal strength in all 8 muscle groups bilaterally). Results are reported as Final score - Initial score. A positive result indicates an increase in strength.
Change in Manual Muscle Test (MMT) at the End of 2 Months of Rest Period IChange from the end of Phase I training (measured at 2 months of Training Phase I) to 2 months of Rest Period IThe strength of each of 8 major muscle groups (per side) in the lower extremities is graded using the standard manual muscle testing technique. Strength is graded from 0 (no muscle activity detected) to 5 (strength with normal range for the muscle group). Scores from all muscle groups are added to obtain the total score. The total score ranges from 0 (unable to produce any muscle activity in all 8 muscle groups bilaterally) to 80 (normal strength in all 8 muscle groups bilaterally). Results are reported as Final score - Initial score. A positive result indicates an increase in strength.
Change in Manual Muscle Test (MMT) at 2 Months of Training Phase IIChange from Baseline II to 2 months of Training Phase IIThe strength of each of 8 major muscle groups (per side) in the lower extremities is graded using the standard manual muscle testing technique. Strength is graded from 0 (no muscle activity detected) to 5 (strength with normal range for the muscle group). Scores from all muscle groups are added to obtain the total score. The total score ranges from 0 (unable to produce any muscle activity in all 8 muscle groups bilaterally) to 80 (normal strength in all 8 muscle groups bilaterally). Results are reported as Final score - Initial score. A positive result indicates an increase in strength.
Change in Manual Muscle Test (MMT) at the End of 2 Months of Rest Period IIChange from the end of Phase II training (measured at 2 months of Training Phase II) to 2 months of Rest Period IIThe strength of each of 8 major muscle groups (per side) in the lower extremities is graded using the standard manual muscle testing technique. Strength is graded from 0 (no muscle activity detected) to 5 (strength with normal range for the muscle group). Scores from all muscle groups are added to obtain the total score. The total score ranges from 0 (unable to produce any muscle activity in all 8 muscle groups bilaterally) to 80 (normal strength in all 8 muscle groups bilaterally). Results are reported as Final score - Initial score. A positive result indicates an increase in strength.
Change in Cutaneomuscular Reflexes at 2 Months of Training Phase IChange from Baseline I to 2 months of Training Phase IReflexes are elicited in standing by electrical stimulation (3 pulses) of the tibial nerve at the ankle using surface electrodes. Responses are recorded with surface electromyography (EMG) in µV.
Change in Cutaneomuscular Reflexes at the End of 2 Months of Rest Period IChange from the end of Phase I training (measured at 2 months of Training Phase I) to 2 months of Rest Period IReflexes are elicited with electrical stimulation (3 pulses) of the tibial nerve at the ankle using surface electrodes. Responses are recorded with surface electromyography (EMG). Responses are typically recorded in standing.
Change in Cutaneomuscular Reflexes at 2 Months of Training Phase IIChange from Baseline II to 2 months of Training Phase IIReflexes are elicited with electrical stimulation (3 pulses) of the tibial nerve at the ankle using surface electrodes. Responses are recorded with surface electromyography (EMG). Responses are typically recorded in standing.
Change in Cutaneomuscular Reflexes at the End of 2 Months of Rest Period IIChange from the end of Phase II training (measured at 2 months of Training Phase II) to 2 months of Rest Period IIReflexes are elicited with electrical stimulation (3 pulses) of the tibial nerve at the ankle using surface electrodes. Responses are recorded with surface electromyography (EMG). Responses are typically recorded in standing.
Change in Transcranial Magnetic Stimulation (TMS) at 2 Months of Training Phase IChange from Baseline I to 2 months of Training Phase ISingle-pulse TMS is applied over the motor cortex, and electromyographic responses are recorded in the tibialis anterior muscles on both legs.
Change in Transcranial Magnetic Stimulation (TMS) at the End of 2 Months of Rest Period IChange from the end of Phase I training (measured at 2 months of Training Phase I) to 2 months of Rest Period ISingle-pulse TMS is applied over the motor cortex, and electromyographic responses are recorded in the tibialis anterior muscles on both legs.
Change in Spinal Cord Injury - Functional Ambulation Profile (SCI-FAP) at 2 Months of Training Phase IChange from Baseline I to 2 months of Training Phase IThis is a 7 item, timed walking test. Participants perform each of the walking tasks and the time to complete each task is recorded. Maximum times are set for each task. An assistance category is assigned based on the walking aids used, with 1 being no aid and 6 being unable to complete the task. A score for each item is calculated as: Time x Assistance factor/Mean able bodied time. A composite (single) score is obtained by summing the scores for all 7 items. The maximum score for the scale is 2100 indicating that the participant was unable to complete any of the 7 tasks within the allowed time. A minimum score of 7 indicates that all tasks were performed with no aids and at the mean able-bodied time. Results are reported as a measure of change: Final score - initial score. A negative result indicates improvement.
Change in Transcranial Magnetic Stimulation (TMS) at the End of 2 Months of Rest Period IIChange from the end of Phase II training (measured at 2 months of Training Phase II) to 2 months of Rest Period IIMaximum evoked potentials were measured and compared to baseline measures for major muscle groups.
Change in Electromyography During Treadmill Walking at 2 Months of Training Phase IChange from Baseline I to 2 months of Training Phase IParticipants walk on a treadmill at a variety of speeds while we record surface electromyography from leg muscles and motion data from electrogoniometers place on the knees.
Change in Electromyography During Treadmill Walking at the End of 2 Months of Rest Period IChange from the end of Phase I training (measured at 2 months of Training Phase I) to 2 months of Rest Period IParticipants walk on a treadmill at a variety of speeds while we record surface electromyography from leg muscles and motion data from electrogoniometers place on the knees.
Change in Electromyography During Treadmill Walking at 2 Months of Training Phase IIChange from Baseline II to 2 months of Training Phase IIParticipants walk on a treadmill at a variety of speeds while we record surface electromyography from leg muscles and motion data from electrogoniometers place on the knees.
Change in Electromyography During Treadmill Walking at the End of 2 Months of Rest Period IIChange from the end of Phase II training (measured at 2 months of Training Phase II) to 2 months of Rest Period IIParticipants walk on a treadmill at a variety of speeds while we record surface electromyography from leg muscles and motion data from electrogoniometers place on the knees.
Change in Transcranial Magnetic Stimulation (TMS) at 2 Months of Training Phase IIChange from Baseline II to 2 months of Training Phase IISingle-pulse TMS is applied over the motor cortex, and electromyographic responses are recorded in the tibialis anterior muscles on both legs.

Countries

Canada

Participant flow

Participants by arm

ArmCount
Endurance First
Participants start with Endurance Training. Participants are trained daily to walk on a treadmill for as fast and as long as possible. A harness supporting part of their body weight is used if needed. Assistance from a trainer is used if needed. A physical therapist supervises the training. Training is 5x/wk for 2 months, followed by a 2-month rest period. Participants then returned for training in the Precision Training 5x/wk for 2 months.Participants train to walk over ground on 15 m straight hallway with obstacles they must step over, and targets they must step onto. This is followed by another 2-month rest.
10
Precision First
Participants start with Precision Training. Participants train to walk over ground on 15 m straight hallway with obstacles they must step over, and targets they must step onto. Training was 5x/wk for 2 months, followed by a 2-month rest period. Participants then returned for Endurance Training 5x/wk for 2 months. Participants are trained to walk on a treadmill for as fast and as long as possible. A harness supporting part of their body weight is used if needed. Assistance from a trainer is used if needed. A physical therapist supervises the training. followed by another 2-month rest.
11
Total21

Withdrawals & dropouts

PeriodReasonFG000FG001
Rest Phase 1Withdrawal by Subject01
Rest Phase 2Lost to Follow-up21
Training Phase 1Format of intervention differed10
Training Phase 1Poor participation in intervention01
Training Phase 2Withdrawal by Subject01

Baseline characteristics

CharacteristicEndurance FirstPrecision FirstTotal
Age, Continuous48.1 years
STANDARD_DEVIATION 14.4
44.0 years
STANDARD_DEVIATION 13.2
45.9 years
STANDARD_DEVIATION 13.3
Region of Enrollment
Canada
10 participants11 participants21 participants
Sex: Female, Male
Female
3 Participants4 Participants7 Participants
Sex: Female, Male
Male
7 Participants7 Participants14 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 100 / 11
serious
Total, serious adverse events
0 / 100 / 11

Outcome results

Primary

Change in Spinal Cord Injury - Functional Ambulation Profile (SCI-FAP) at Completion of Study

This is a 7 item, timed walking test. Participants perform each of the walking tasks and the time to complete each task is recorded. Maximum times are set for each task. An assistance category is assigned based on the walking aids used, with 1 being no aid and 6 being unable to complete the task. A score for each item is calculated as: Time x Assistance factor/Mean able bodied time. A composite (single) score is obtained by summing the scores for all 7 items. The maximum score for the scale is 2100 indicating that the participant was unable to complete any of the 7 tasks within the allowed time. A minimum score of 7 indicates that all tasks were performed with no aids and at the mean able-bodied time. Results are reported as a measure of change: Final score - initial score. A negative result indicates improvement.

Time frame: Change from Baseline I to the end of the study (i.e., end of Rest Period II, which was ~8 months after the beginning of the study)

ArmMeasureValue (MEAN)Dispersion
Endurance FirstChange in Spinal Cord Injury - Functional Ambulation Profile (SCI-FAP) at Completion of Study-128.77 units on a scaleStandard Deviation 180.73
Precision FirstChange in Spinal Cord Injury - Functional Ambulation Profile (SCI-FAP) at Completion of Study-64.07 units on a scaleStandard Deviation 77.24
Secondary

Change in 10 Meter Walk Test at a Fast Speed [10MWT(f)] at 2 Months of Training Phase I

Participants walk as quickly as they are able to along a 14 meter path on a smooth floor. The middle 10 m is timed. Speed over 10 m is calculated as 10 m/Time. Results are calculated as: Final speed - initial speed.

Time frame: Change from Baseline I to 2 months of Training Phase I

Population: Measure was added to study protocol midway through study. 5 out of 19 participants did not complete this measure at this time point. Data analysed for all participants who performed this measure.

ArmMeasureValue (MEAN)Dispersion
Endurance FirstChange in 10 Meter Walk Test at a Fast Speed [10MWT(f)] at 2 Months of Training Phase I0.07 m/sStandard Deviation 0.09
Precision FirstChange in 10 Meter Walk Test at a Fast Speed [10MWT(f)] at 2 Months of Training Phase I0.21 m/sStandard Deviation 0.2
Secondary

Change in 10 Meter Walk Test at a Fast Speed [10MWT(f)] at 2 Months of Training Phase II

Participants walk as quickly as they are able to along a 14 meter path on a smooth floor. The middle 10 m is timed. Speed over 10 m is calculated as 10 m/Time. Results are calculated as: Final speed - initial speed.

Time frame: Change from Baseline II to 2 months of Training Phase II

Population: Measure was added to study protocol midway through study. 3 out of 18 participants did not complete this measure at this time point. Data analysed for all participants who performed this measure.

ArmMeasureValue (MEAN)Dispersion
Endurance FirstChange in 10 Meter Walk Test at a Fast Speed [10MWT(f)] at 2 Months of Training Phase II0.06 m/sStandard Deviation 0.09
Precision FirstChange in 10 Meter Walk Test at a Fast Speed [10MWT(f)] at 2 Months of Training Phase II0.09 m/sStandard Deviation 0.13
Secondary

Change in 10 Meter Walk Test at a Fast Speed [10MWT(f)] at the End of 2 Months of Rest Period I

Participants walk as quickly as they are able to along a 14 meter path on a smooth floor. The middle 10 m is timed. Speed over 10 m is calculated as 10 m/Time. Results are calculated as: Final speed - initial speed.

Time frame: Change from the end of Phase I training (measured at 2 months of Training Phase I) to 2 months of Rest Period I

Population: Measure was added to study protocol midway through study. 4 out of 18 participants did not complete this measure at this time point. Data analysed for all participants who performed this measure.

ArmMeasureValue (MEAN)Dispersion
Endurance FirstChange in 10 Meter Walk Test at a Fast Speed [10MWT(f)] at the End of 2 Months of Rest Period I0.04 m/sStandard Deviation 0.18
Precision FirstChange in 10 Meter Walk Test at a Fast Speed [10MWT(f)] at the End of 2 Months of Rest Period I0.14 m/sStandard Deviation 0.11
Secondary

Change in 10 Meter Walk Test at a Fast Speed [10MWT(f)] at the End of 2 Months of Rest Period II

Participants walk as quickly as they are able to along a 14 meter path on a smooth floor. The middle 10 m is timed. Speed over 10 m is calculated as 10 m/Time. Results are calculated as: Final speed - initial speed.

Time frame: Change from the end of Phase II training (measured at 2 months of Training Phase II) to 2 months of Rest Period II

Population: Measure was added to study protocol midway through study. 2 out of 16 participants did not complete this measure at this time point. Data analysed for all participants who performed this measure.

ArmMeasureValue (MEAN)Dispersion
Endurance FirstChange in 10 Meter Walk Test at a Fast Speed [10MWT(f)] at the End of 2 Months of Rest Period II-0.09 m/sStandard Deviation 0.11
Precision FirstChange in 10 Meter Walk Test at a Fast Speed [10MWT(f)] at the End of 2 Months of Rest Period II0.12 m/sStandard Deviation 0.28
Secondary

Change in 10 Meter Walk Test at a Self-selected Speed [10MWT(ss)] at 2 Months of Training Phase II

Participants walk along a 14 meter path on a smooth floor at a comfortable pace. The middle 10 m is timed. Speed over 10 m is calculated as 10 m/Time. Results are calculated as: Final speed - initial speed.

Time frame: Change from Baseline II to 2 months of Training Phase II

ArmMeasureValue (MEAN)Dispersion
Endurance FirstChange in 10 Meter Walk Test at a Self-selected Speed [10MWT(ss)] at 2 Months of Training Phase II0.02 m/sStandard Deviation 0.04
Precision FirstChange in 10 Meter Walk Test at a Self-selected Speed [10MWT(ss)] at 2 Months of Training Phase II0.06 m/sStandard Deviation 0.15
Secondary

Change in 10 Meter Walk Test at a Self-selected Speed [10MWT(ss)] at the End of 2 Months of Rest Period I

Participants walk along a 14 meter path on a smooth floor at a comfortable pace. The middle 10 m is timed. Speed over 10 m is calculated as 10 m/Time. Results are calculated as: Final speed - initial speed.

Time frame: Change from the end of Phase I training (measured at 2 months of Training Phase I) to 2 months of Rest Period I

ArmMeasureValue (MEAN)Dispersion
Endurance FirstChange in 10 Meter Walk Test at a Self-selected Speed [10MWT(ss)] at the End of 2 Months of Rest Period I0.04 m/sStandard Deviation 0.12
Precision FirstChange in 10 Meter Walk Test at a Self-selected Speed [10MWT(ss)] at the End of 2 Months of Rest Period I0.09 m/sStandard Deviation 0.19
Secondary

Change in 10 Meter Walk Test at a Self-selected Speed [10MWT(ss)] at the End of 2 Months of Rest Period II

Participants walk along a 14 meter path on a smooth floor at a comfortable pace. The middle 10 m is timed. Speed over 10 m is calculated as 10 m/Time. Results are calculated as: Final speed - initial speed.

Time frame: Change from the end of Phase II training (measured at 2 months of Training Phase II) to 2 months of Rest Period II

ArmMeasureValue (MEAN)Dispersion
Endurance FirstChange in 10 Meter Walk Test at a Self-selected Speed [10MWT(ss)] at the End of 2 Months of Rest Period II-0.02 m/sStandard Deviation 0.12
Precision FirstChange in 10 Meter Walk Test at a Self-selected Speed [10MWT(ss)] at the End of 2 Months of Rest Period II-0.09 m/sStandard Deviation 0.3
Secondary

Change in 10 Metre Walk Test at a Self-selected Speed [10MWT(ss)] at 2 Months of Training Phase I

Participants walk along a 14 meter path on a smooth floor at a comfortable pace. The middle 10 m is timed. Speed over 10 m is calculated as 10 m/Time. Results are calculated as: Final speed - initial speed.

Time frame: Change from Baseline I to 2 months of Training Phase I

ArmMeasureValue (MEAN)Dispersion
Endurance FirstChange in 10 Metre Walk Test at a Self-selected Speed [10MWT(ss)] at 2 Months of Training Phase I0.07 m/sStandard Deviation 0.06
Precision FirstChange in 10 Metre Walk Test at a Self-selected Speed [10MWT(ss)] at 2 Months of Training Phase I0.06 m/sStandard Deviation 0.08
Secondary

Change in 6 Minute Walk Test (6MWT) at 2 Months of Training Phase I

Participants walk for as far as possible in 6 min along a 25m hallway.

Time frame: Change from Baseline I to 2 months of Training Phase I

ArmMeasureValue (MEAN)Dispersion
Endurance FirstChange in 6 Minute Walk Test (6MWT) at 2 Months of Training Phase I32.75 metresStandard Deviation 40.07
Precision FirstChange in 6 Minute Walk Test (6MWT) at 2 Months of Training Phase I17.43 metresStandard Deviation 26.67
Secondary

Change in 6 Minute Walk Test (6MWT) at 2 Months of Training Phase II

Participants walk for as far as possible in 6 min along a 25m hallway. Total distance walked in the time is measured. Results are calculated as : Distance walked at end of period - Distance walked at beginning of period.

Time frame: Change from Baseline II to 2 months of Training Phase II

ArmMeasureValue (MEAN)Dispersion
Endurance FirstChange in 6 Minute Walk Test (6MWT) at 2 Months of Training Phase II3.9 metresStandard Deviation 11.11
Precision FirstChange in 6 Minute Walk Test (6MWT) at 2 Months of Training Phase II25.78 metresStandard Deviation 26.6
Secondary

Change in 6 Minute Walk Test (6MWT) at the End of 2 Months of Rest Period I

Participants walk for as far as possible in 6 min along a 25m hallway. Total distance walked in the time is measured. Results are calculated as : Distance walked at end of period - Distance walked at beginning of period.

Time frame: Change from the end of Phase I training (measured at 2 months of Training Phase I) to 2 months of Rest Period I

ArmMeasureValue (MEAN)Dispersion
Endurance FirstChange in 6 Minute Walk Test (6MWT) at the End of 2 Months of Rest Period I6.78 metresStandard Deviation 32.69
Precision FirstChange in 6 Minute Walk Test (6MWT) at the End of 2 Months of Rest Period I32.23 metresStandard Deviation 46.41
Secondary

Change in 6 Minute Walk Test (6MWT) at the End of 2 Months of Rest Period II

Participants walk for as far as possible in 6 min along a 25m hallway. Total distance walked in the time is measured. Results are calculated as : Distance walked at end of period - Distance walked at beginning of period.

Time frame: Change from the end of Phase II training to 2 months of Rest Period II

ArmMeasureValue (MEAN)Dispersion
Endurance FirstChange in 6 Minute Walk Test (6MWT) at the End of 2 Months of Rest Period II-14.63 metresStandard Deviation 29.94
Precision FirstChange in 6 Minute Walk Test (6MWT) at the End of 2 Months of Rest Period II17.00 metresStandard Deviation 23.6
Secondary

Change in Activities-specific Balance Confidence Scale (ABC) at 2 Months of Training Phase I

A survey with 16 questions regarding the participants confidence in their ability to perform specific tasks requiring balance. Participants rate their confidence as a percentage from 0% (no confidence in their ability to perform the task) to 100% 9 completely confident in their ability to complete the task safely. Total score is calculated as: Sum of item scores/16 and is expressed as a percentage. Results are reported as Final score - Initial score. A positive result indicates a higher level of confidence in ability.

Time frame: Change from Baseline I to 2 months of Training Phase I

ArmMeasureValue (MEAN)Dispersion
Endurance FirstChange in Activities-specific Balance Confidence Scale (ABC) at 2 Months of Training Phase I4.15 percentage of confidence in balanceStandard Deviation 9.54
Precision FirstChange in Activities-specific Balance Confidence Scale (ABC) at 2 Months of Training Phase I3.15 percentage of confidence in balanceStandard Deviation 8.79
Secondary

Change in Activities-specific Balance Confidence Scale (ABC) at 2 Months of Training Phase II

A survey with 16 questions regarding the participants confidence in their ability to perform specific tasks requiring balance. Participants rate their confidence as a percentage from 0% (no confidence in their ability to perform the task) to 100% 9 completely confident in their ability to complete the task safely. Total score is calculated as: Sum of item scores/16 and is expressed as a percentage. Results are reported as Final score - Initial score. A positive result indicates a higher level of confidence in ability.

Time frame: Change from Baseline II to 2 months of Training Phase II

ArmMeasureValue (MEAN)Dispersion
Endurance FirstChange in Activities-specific Balance Confidence Scale (ABC) at 2 Months of Training Phase II3.78 Percentage of confidence in balanceStandard Deviation 5.37
Precision FirstChange in Activities-specific Balance Confidence Scale (ABC) at 2 Months of Training Phase II6.48 Percentage of confidence in balanceStandard Deviation 10.52
Secondary

Change in Activities-specific Balance Confidence Scale (ABC) at the End of 2 Months of Rest Period I

A survey with 16 questions regarding the participants confidence in their ability to perform specific tasks requiring balance. Participants rate their confidence as a percentage from 0% (no confidence in their ability to perform the task) to 100% 9 completely confident in their ability to complete the task safely. Total score is calculated as: Sum of item scores/16 and is expressed as a percentage. Results are reported as Final score - Initial score. A positive result indicates a higher level of confidence in ability.

Time frame: Change from the end of Phase I training (measured at 2 months of Training Phase I) to 2 months of Rest Period I

ArmMeasureValue (MEAN)Dispersion
Endurance FirstChange in Activities-specific Balance Confidence Scale (ABC) at the End of 2 Months of Rest Period I0.38 percentage of confidence in balanceStandard Deviation 8.23
Precision FirstChange in Activities-specific Balance Confidence Scale (ABC) at the End of 2 Months of Rest Period I1.70 percentage of confidence in balanceStandard Deviation 3.9
Secondary

Change in Activities-specific Balance Confidence Scale (ABC) at the End of 2 Months of Rest Period II

A survey with 16 questions regarding the participants confidence in their ability to perform specific tasks requiring balance. Participants rate their confidence as a percentage from 0% (no confidence in their ability to perform the task) to 100% 9 completely confident in their ability to complete the task safely. Total score is calculated as: Sum of item scores/16 and is expressed as a percentage. Results are reported as Final score - Initial score. A positive result indicates a higher level of confidence in ability.

Time frame: Change from the end of Phase II training (measured at 2 months of Training Phase II) to 2 months of Rest Period II

ArmMeasureValue (MEAN)Dispersion
Endurance FirstChange in Activities-specific Balance Confidence Scale (ABC) at the End of 2 Months of Rest Period II-0.08 percentage of confidence in balanceStandard Deviation 5.2
Precision FirstChange in Activities-specific Balance Confidence Scale (ABC) at the End of 2 Months of Rest Period II-0.63 percentage of confidence in balanceStandard Deviation 5.44
Secondary

Change in Center for Epidemiologic Studies - Depression Scale (CES-D) at 2 Months of Training Phase I

A 20 question survey to measure current level of depressive symptoms. The participant ranks their emotional state or actions for each question on an ordinal scale of 0 to 3, with 0 indicating rarely or never and 3 being most of the time. A minimum score of 0 indicates no depressive symptoms, and a score of 10 or greater is considered indicative of depression. The max score for the scale is 60. Results are reported as Final score - Initial score. A negative result indicates a lower level of depression.

Time frame: Change from Baseline I to 2 months of Training Phase I

ArmMeasureValue (MEAN)Dispersion
Endurance FirstChange in Center for Epidemiologic Studies - Depression Scale (CES-D) at 2 Months of Training Phase I-3.85 units on a scaleStandard Deviation 5.4
Precision FirstChange in Center for Epidemiologic Studies - Depression Scale (CES-D) at 2 Months of Training Phase I-2.42 units on a scaleStandard Deviation 6.95
Secondary

Change in Center for Epidemiologic Studies - Depression Scale (CES-D) at 2 Months of Training Phase II

A 20 question survey to measure current level of depressive symptoms.The participant ranks their emotional state or actions for each question on an ordinal scale of 0 to 3, with 0 indicating rarely or never and 3 being most of the time. A minimum score of 0 indicates no depressive symptoms, and a score of 10 or greater is considered indicative of depression. The max score for the scale is 60. Results are reported as Final score - Initial score. A negative result indicates a lower level of depression.

Time frame: Change from Baseline II to 2 months of Training Phase II

ArmMeasureValue (MEAN)Dispersion
Endurance FirstChange in Center for Epidemiologic Studies - Depression Scale (CES-D) at 2 Months of Training Phase II-2.75 units on a scaleStandard Deviation 2.95
Precision FirstChange in Center for Epidemiologic Studies - Depression Scale (CES-D) at 2 Months of Training Phase II-0.53 units on a scaleStandard Deviation 3.7
Secondary

Change in Center for Epidemiologic Studies - Depression Scale (CES-D) at the End of 2 Months of Rest Period I

A 20 question survey to measure current level of depressive symptoms.The participant ranks their emotional state or actions for each question on an ordinal scale of 0 to 3, with 0 indicating rarely or never and 3 being most of the time. A minimum score of 0 indicates no depressive symptoms, and a score of 10 or greater is considered indicative of depression. The max score for the scale is 60. Results are reported as Final score - Initial score. A negative result indicates a lower level of depression.

Time frame: Change from the end of Phase I training (measured at 2 months of Training Phase I) to 2 months of Rest Period I

ArmMeasureValue (MEAN)Dispersion
Endurance FirstChange in Center for Epidemiologic Studies - Depression Scale (CES-D) at the End of 2 Months of Rest Period I0.61 units on a scaleStandard Deviation 1.98
Precision FirstChange in Center for Epidemiologic Studies - Depression Scale (CES-D) at the End of 2 Months of Rest Period I-0.64 units on a scaleStandard Deviation 3.27
Secondary

Change in Center for Epidemiologic Studies - Depression Scale (CES-D) at the End of 2 Months of Rest Period II

A 20 question survey to measure current level of depressive symptoms.The participant ranks their emotional state or actions for each question on an ordinal scale of 0 to 3, with 0 indicating rarely or never and 3 being most of the time. A minimum score of 0 indicates no depressive symptoms, and a score of 10 or greater is considered indicative of depression. The max score for the scale is 60. Results are reported as Final score - Initial score. A negative result indicates a lower level of depression.

Time frame: Change from the end of Phase II training (measured at 2 months of Training Phase II) to 2 months of Rest Period II

ArmMeasureValue (MEAN)Dispersion
Endurance FirstChange in Center for Epidemiologic Studies - Depression Scale (CES-D) at the End of 2 Months of Rest Period II3.25 units on a scaleStandard Deviation 5.92
Precision FirstChange in Center for Epidemiologic Studies - Depression Scale (CES-D) at the End of 2 Months of Rest Period II-0.25 units on a scaleStandard Deviation 3.24
Secondary

Change in Cutaneomuscular Reflexes at 2 Months of Training Phase I

Reflexes are elicited in standing by electrical stimulation (3 pulses) of the tibial nerve at the ankle using surface electrodes. Responses are recorded with surface electromyography (EMG) in µV.

Time frame: Change from Baseline I to 2 months of Training Phase I

Population: Data from 6 participants could not be analysed due to absence of reflex, or difficulty with EMG signals. Remaining 13 were analysed.

ArmMeasureValue (MEAN)Dispersion
Endurance FirstChange in Cutaneomuscular Reflexes at 2 Months of Training Phase I-6.84 µVStandard Deviation 6
Precision FirstChange in Cutaneomuscular Reflexes at 2 Months of Training Phase I2.36 µVStandard Deviation 17.35
Secondary

Change in Cutaneomuscular Reflexes at 2 Months of Training Phase II

Reflexes are elicited with electrical stimulation (3 pulses) of the tibial nerve at the ankle using surface electrodes. Responses are recorded with surface electromyography (EMG). Responses are typically recorded in standing.

Time frame: Change from Baseline II to 2 months of Training Phase II

Population: Data from 5 participants could not be analysed due to absence of reflex, or difficulty with EMG signals. Remaining 13 were analysed.

ArmMeasureValue (MEAN)Dispersion
Endurance FirstChange in Cutaneomuscular Reflexes at 2 Months of Training Phase II3.01 µVStandard Deviation 7.09
Precision FirstChange in Cutaneomuscular Reflexes at 2 Months of Training Phase II-5.97 µVStandard Deviation 11.14
Secondary

Change in Cutaneomuscular Reflexes at the End of 2 Months of Rest Period I

Reflexes are elicited with electrical stimulation (3 pulses) of the tibial nerve at the ankle using surface electrodes. Responses are recorded with surface electromyography (EMG). Responses are typically recorded in standing.

Time frame: Change from the end of Phase I training (measured at 2 months of Training Phase I) to 2 months of Rest Period I

Population: Data was analysed for the 13 participants who provided CMR data in Training phase 1 in order to dtermine if training effect was maintained. 1 out 13 withdrew and 1 did not produce adequate reflex activity to allow analysis

ArmMeasureValue (MEAN)Dispersion
Endurance FirstChange in Cutaneomuscular Reflexes at the End of 2 Months of Rest Period I0.18 µVStandard Deviation 5.6
Precision FirstChange in Cutaneomuscular Reflexes at the End of 2 Months of Rest Period I4.35 µVStandard Deviation 6.92
Secondary

Change in Cutaneomuscular Reflexes at the End of 2 Months of Rest Period II

Reflexes are elicited with electrical stimulation (3 pulses) of the tibial nerve at the ankle using surface electrodes. Responses are recorded with surface electromyography (EMG). Responses are typically recorded in standing.

Time frame: Change from the end of Phase II training (measured at 2 months of Training Phase II) to 2 months of Rest Period II

Population: Data was analysed for the 13 participants who provided CMR data in Training phase 1 to determine whether training effect was maintained. 1 out 13 withdrew and 3 did not produce adequate reflex activity to allow analysis.

ArmMeasureValue (MEAN)Dispersion
Endurance FirstChange in Cutaneomuscular Reflexes at the End of 2 Months of Rest Period II2.13 µVStandard Deviation 5.56
Precision FirstChange in Cutaneomuscular Reflexes at the End of 2 Months of Rest Period II1.82 µVStandard Deviation 14.42
Secondary

Change in Electromyography During Treadmill Walking at 2 Months of Training Phase I

Participants walk on a treadmill at a variety of speeds while we record surface electromyography from leg muscles and motion data from electrogoniometers place on the knees.

Time frame: Change from Baseline I to 2 months of Training Phase I

Population: Data from 6 participants could not be analysed due to absence of reflex, or difficulty with EMG signals. Remaining 13 were analysed.

ArmMeasureValue (MEAN)Dispersion
Endurance FirstChange in Electromyography During Treadmill Walking at 2 Months of Training Phase I0.28 µVStandard Deviation 3.76
Precision FirstChange in Electromyography During Treadmill Walking at 2 Months of Training Phase I0.14 µVStandard Deviation 5.24
Secondary

Change in Electromyography During Treadmill Walking at 2 Months of Training Phase II

Participants walk on a treadmill at a variety of speeds while we record surface electromyography from leg muscles and motion data from electrogoniometers place on the knees.

Time frame: Change from Baseline II to 2 months of Training Phase II

Population: Data from 5 participants could not be analysed due to absence of reflex, or difficulty with EMG signals. Remaining 13 were analysed.

ArmMeasureValue (MEAN)Dispersion
Endurance FirstChange in Electromyography During Treadmill Walking at 2 Months of Training Phase II0.73 µVStandard Deviation 2.76
Precision FirstChange in Electromyography During Treadmill Walking at 2 Months of Training Phase II-0.26 µVStandard Deviation 7.73
Secondary

Change in Electromyography During Treadmill Walking at the End of 2 Months of Rest Period I

Participants walk on a treadmill at a variety of speeds while we record surface electromyography from leg muscles and motion data from electrogoniometers place on the knees.

Time frame: Change from the end of Phase I training (measured at 2 months of Training Phase I) to 2 months of Rest Period I

Population: Data was analysed for the 13 participants who provided CMR data in Training phase 1 to determine if training effect was maintained. 1 out 13 withdrew and 1 did not produce adequate reflex activity to allow analysis

ArmMeasureValue (MEAN)Dispersion
Endurance FirstChange in Electromyography During Treadmill Walking at the End of 2 Months of Rest Period I1.04 µVStandard Deviation 3.54
Precision FirstChange in Electromyography During Treadmill Walking at the End of 2 Months of Rest Period I0.38 µVStandard Deviation 6.43
Secondary

Change in Electromyography During Treadmill Walking at the End of 2 Months of Rest Period II

Participants walk on a treadmill at a variety of speeds while we record surface electromyography from leg muscles and motion data from electrogoniometers place on the knees.

Time frame: Change from the end of Phase II training (measured at 2 months of Training Phase II) to 2 months of Rest Period II

Population: Data was analysed for the 13 participants who provided CMR data in Training phase 1. 1 out 13 withdrew and 3 did not produce adequate reflex activity to allow analysis.

ArmMeasureValue (MEAN)Dispersion
Endurance FirstChange in Electromyography During Treadmill Walking at the End of 2 Months of Rest Period II0.53 µVStandard Deviation 3.11
Precision FirstChange in Electromyography During Treadmill Walking at the End of 2 Months of Rest Period II0.63 µVStandard Deviation 6.17
Secondary

Change in Manual Muscle Test (MMT) at 2 Months of Training Phase I

The strength of each of 8 major muscle groups (per side) in the lower extremities is graded using the standard manual muscle testing technique. Strength is graded from 0 (no muscle activity detected) to 5 (strength with normal range for the muscle group). Scores from all muscle groups are added to obtain the total score. The total score ranges from 0 (unable to produce any muscle activity in all 8 muscle groups bilaterally) to 80 (normal strength in all 8 muscle groups bilaterally). Results are reported as Final score - Initial score. A positive result indicates an increase in strength.

Time frame: Change from Baseline I to 2 months of Training Phase I

ArmMeasureValue (MEAN)Dispersion
Endurance FirstChange in Manual Muscle Test (MMT) at 2 Months of Training Phase I1.29 units on a scaleStandard Deviation 2.51
Precision FirstChange in Manual Muscle Test (MMT) at 2 Months of Training Phase I2.50 units on a scaleStandard Deviation 5.6
Secondary

Change in Manual Muscle Test (MMT) at 2 Months of Training Phase II

The strength of each of 8 major muscle groups (per side) in the lower extremities is graded using the standard manual muscle testing technique. Strength is graded from 0 (no muscle activity detected) to 5 (strength with normal range for the muscle group). Scores from all muscle groups are added to obtain the total score. The total score ranges from 0 (unable to produce any muscle activity in all 8 muscle groups bilaterally) to 80 (normal strength in all 8 muscle groups bilaterally). Results are reported as Final score - Initial score. A positive result indicates an increase in strength.

Time frame: Change from Baseline II to 2 months of Training Phase II

Population: This measure was accidentally omitted for 1 participant at beginning of this phase. Data analysed for all participants who performed this measure.

ArmMeasureValue (MEAN)Dispersion
Endurance FirstChange in Manual Muscle Test (MMT) at 2 Months of Training Phase II1.22 units on a scaleStandard Deviation 2.9
Precision FirstChange in Manual Muscle Test (MMT) at 2 Months of Training Phase II0.56 units on a scaleStandard Deviation 3.21
Secondary

Change in Manual Muscle Test (MMT) at the End of 2 Months of Rest Period I

The strength of each of 8 major muscle groups (per side) in the lower extremities is graded using the standard manual muscle testing technique. Strength is graded from 0 (no muscle activity detected) to 5 (strength with normal range for the muscle group). Scores from all muscle groups are added to obtain the total score. The total score ranges from 0 (unable to produce any muscle activity in all 8 muscle groups bilaterally) to 80 (normal strength in all 8 muscle groups bilaterally). Results are reported as Final score - Initial score. A positive result indicates an increase in strength.

Time frame: Change from the end of Phase I training (measured at 2 months of Training Phase I) to 2 months of Rest Period I

Population: This measure was accidentally omitted for 1 participant at the end of this phase. Data analysed for all participants who performed this measure.

ArmMeasureValue (MEAN)Dispersion
Endurance FirstChange in Manual Muscle Test (MMT) at the End of 2 Months of Rest Period I-2.45 units on a scaleStandard Deviation 4.19
Precision FirstChange in Manual Muscle Test (MMT) at the End of 2 Months of Rest Period I-1.06 units on a scaleStandard Deviation 3.13
Secondary

Change in Manual Muscle Test (MMT) at the End of 2 Months of Rest Period II

The strength of each of 8 major muscle groups (per side) in the lower extremities is graded using the standard manual muscle testing technique. Strength is graded from 0 (no muscle activity detected) to 5 (strength with normal range for the muscle group). Scores from all muscle groups are added to obtain the total score. The total score ranges from 0 (unable to produce any muscle activity in all 8 muscle groups bilaterally) to 80 (normal strength in all 8 muscle groups bilaterally). Results are reported as Final score - Initial score. A positive result indicates an increase in strength.

Time frame: Change from the end of Phase II training (measured at 2 months of Training Phase II) to 2 months of Rest Period II

ArmMeasureValue (MEAN)Dispersion
Endurance FirstChange in Manual Muscle Test (MMT) at the End of 2 Months of Rest Period II-3.00 units on a scaleStandard Deviation 3.36
Precision FirstChange in Manual Muscle Test (MMT) at the End of 2 Months of Rest Period II0.07 units on a scaleStandard Deviation 4.76
Secondary

Change in Spinal Cord Injury - Functional Ambulation Profile (SCI-FAP) at 2 Months of Training Phase I

This is a 7 item, timed walking test. Participants perform each of the walking tasks and the time to complete each task is recorded. Maximum times are set for each task. An assistance category is assigned based on the walking aids used, with 1 being no aid and 6 being unable to complete the task. A score for each item is calculated as: Time x Assistance factor/Mean able bodied time. A composite (single) score is obtained by summing the scores for all 7 items. The maximum score for the scale is 2100 indicating that the participant was unable to complete any of the 7 tasks within the allowed time. A minimum score of 7 indicates that all tasks were performed with no aids and at the mean able-bodied time. Results are reported as a measure of change: Final score - initial score. A negative result indicates improvement.

Time frame: Change from Baseline I to 2 months of Training Phase I

ArmMeasureValue (MEAN)Dispersion
Endurance FirstChange in Spinal Cord Injury - Functional Ambulation Profile (SCI-FAP) at 2 Months of Training Phase I-129.09 units on a scaleStandard Deviation 165.06
Precision FirstChange in Spinal Cord Injury - Functional Ambulation Profile (SCI-FAP) at 2 Months of Training Phase I-69.51 units on a scaleStandard Deviation 106.51
Secondary

Change in Spinal Cord Injury - Functional Ambulation Profile (SCI-FAP) at 2 Months of Training Phase II

This is a 7 item, timed walking test. Participants perform each of the walking tasks and the time to complete each task is recorded. Maximum times are set for each task. An assistance category is assigned based on the walking aids used, with 1 being no aid and 6 being unable to complete the task. A score for each item is calculated as: Time x Assistance factor/Mean able bodied time. A composite (single) score is obtained by summing the scores for all 7 items. The maximum score for the scale is 2100 indicating that the participant was unable to complete any of the 7 tasks within the allowed time. A minimum score of 7 indicates that all tasks were performed with no aids and at the mean able-bodied time. Results are reported as a measure of change: Final score - initial score. A negative result indicates improvement.

Time frame: Change from Baseline II to 2 months of Training Phase II

ArmMeasureValue (MEAN)Dispersion
Endurance FirstChange in Spinal Cord Injury - Functional Ambulation Profile (SCI-FAP) at 2 Months of Training Phase II-15.28 units on a scaleStandard Deviation 31.74
Precision FirstChange in Spinal Cord Injury - Functional Ambulation Profile (SCI-FAP) at 2 Months of Training Phase II-13.35 units on a scaleStandard Deviation 31.58
p-value: 0.04366667t-test, 2 sided
Secondary

Change in Spinal Cord Injury - Functional Ambulation Profile (SCI-FAP) at the End of 2 Months of Rest Period I

This is a 7 item, timed walking test. Participants perform each of the walking tasks and the time to complete each task is recorded. Maximum times are set for each task. An assistance category is assigned based on the walking aids used, with 1 being no aid and 6 being unable to complete the task. A score for each item is calculated as: Time x Assistance factor/Mean able bodied time. A composite (single) score is obtained by summing the scores for all 7 items. The maximum score for the scale is 2100 indicating that the participant was unable to complete any of the 7 tasks within the allowed time. A minimum score of 7 indicates that all tasks were performed with no aids and at the mean able-bodied time. Results are reported as a measure of change: Final score - initial score. A negative result indicates improvement.

Time frame: Change from the end of Phase I training (measured at 2 months of Training Phase I) to 2 months of Rest Period I

ArmMeasureValue (MEAN)Dispersion
Endurance FirstChange in Spinal Cord Injury - Functional Ambulation Profile (SCI-FAP) at the End of 2 Months of Rest Period I-1.04 units on a scaleStandard Deviation 49.67
Precision FirstChange in Spinal Cord Injury - Functional Ambulation Profile (SCI-FAP) at the End of 2 Months of Rest Period I10.34 units on a scaleStandard Deviation 74.23
Secondary

Change in Spinal Cord Injury - Functional Ambulation Profile (SCI-FAP) at the End of 2 Months of Rest Period II

This is a 7 item, timed walking test. Participants perform each of the walking tasks and the time to complete each task is recorded. Maximum times are set for each task. An assistance category is assigned based on the walking aids used, with 1 being no aid and 6 being unable to complete the task. A score for each item is calculated as: Time x Assistance factor/Mean able bodied time. A composite (single) score is obtained by summing the scores for all 7 items. The maximum score for the scale is 2100 indicating that the participant was unable to complete any of the 7 tasks within the allowed time. A minimum score of 7 indicates that all tasks were performed with no aids and at the mean able-bodied time. Results are reported as a measure of change: Final score - initial score. A negative result indicates improvement.

Time frame: Change from the end of Phase II training (measured at 2 months of Training Phase II) to 2 months of Rest Period II

ArmMeasureValue (MEAN)Dispersion
Endurance FirstChange in Spinal Cord Injury - Functional Ambulation Profile (SCI-FAP) at the End of 2 Months of Rest Period II1.61 units on a scaleStandard Deviation 34.13
Precision FirstChange in Spinal Cord Injury - Functional Ambulation Profile (SCI-FAP) at the End of 2 Months of Rest Period II16.10 units on a scaleStandard Deviation 63.86
Secondary

Change in Transcranial Magnetic Stimulation (TMS) at 2 Months of Training Phase I

Single-pulse TMS is applied over the motor cortex, and electromyographic responses are recorded in the tibialis anterior muscles on both legs.

Time frame: Change from Baseline I to 2 months of Training Phase I

ArmMeasureValue (MEAN)Dispersion
Endurance FirstChange in Transcranial Magnetic Stimulation (TMS) at 2 Months of Training Phase I122.9 Percentage of baseline mepStandard Error 7.8
Precision FirstChange in Transcranial Magnetic Stimulation (TMS) at 2 Months of Training Phase I113.9 Percentage of baseline mepStandard Error 9
Secondary

Change in Transcranial Magnetic Stimulation (TMS) at 2 Months of Training Phase II

Single-pulse TMS is applied over the motor cortex, and electromyographic responses are recorded in the tibialis anterior muscles on both legs.

Time frame: Change from Baseline II to 2 months of Training Phase II

ArmMeasureValue (MEAN)Dispersion
Endurance FirstChange in Transcranial Magnetic Stimulation (TMS) at 2 Months of Training Phase II124.3 percentage of baseline mepStandard Error 12.4
Precision FirstChange in Transcranial Magnetic Stimulation (TMS) at 2 Months of Training Phase II111.0 percentage of baseline mepStandard Error 9.7
Secondary

Change in Transcranial Magnetic Stimulation (TMS) at the End of 2 Months of Rest Period I

Single-pulse TMS is applied over the motor cortex, and electromyographic responses are recorded in the tibialis anterior muscles on both legs.

Time frame: Change from the end of Phase I training (measured at 2 months of Training Phase I) to 2 months of Rest Period I

ArmMeasureValue (MEAN)Dispersion
Endurance FirstChange in Transcranial Magnetic Stimulation (TMS) at the End of 2 Months of Rest Period I115.1 percentage of baseline mepStandard Error 14.2
Precision FirstChange in Transcranial Magnetic Stimulation (TMS) at the End of 2 Months of Rest Period I121.7 percentage of baseline mepStandard Error 7.1
Secondary

Change in Transcranial Magnetic Stimulation (TMS) at the End of 2 Months of Rest Period II

Maximum evoked potentials were measured and compared to baseline measures for major muscle groups.

Time frame: Change from the end of Phase II training (measured at 2 months of Training Phase II) to 2 months of Rest Period II

ArmMeasureValue (MEAN)Dispersion
Endurance FirstChange in Transcranial Magnetic Stimulation (TMS) at the End of 2 Months of Rest Period II141.0 percentage of baseline MEPStandard Error 17.1
Precision FirstChange in Transcranial Magnetic Stimulation (TMS) at the End of 2 Months of Rest Period II111.6 percentage of baseline MEPStandard Error 10.4
Secondary

Change in Walking Index for Spinal Cord Injury Version II Maximum [WISCI-II (Max)] at 2 Months of Training Phase I

Participants are scored from 0 to 20 based on the least amount of assistance/aid they require to walk a distance of 10 meters. Walking aids and physical assistance provided are ranked on an ordinal scale from 1 to 20. A score of 0 indicates the participant is unable to walk 10 m, 20 indicates no aids are required to complete the task. Results are reported as Final score - Initial score. A positive result indicates that less assistance was required.

Time frame: Change from Baseline I to 2 months of Training Phase I

Population: Measure was added to study protocol midway through study. 3 out of 19 participants did not complete this measure at this time point. Data analysed for all participants who performed this measure.

ArmMeasureValue (MEAN)Dispersion
Endurance FirstChange in Walking Index for Spinal Cord Injury Version II Maximum [WISCI-II (Max)] at 2 Months of Training Phase I0.73 units on a scaleStandard Deviation 1.08
Precision FirstChange in Walking Index for Spinal Cord Injury Version II Maximum [WISCI-II (Max)] at 2 Months of Training Phase I1.63 units on a scaleStandard Deviation 2.39
Secondary

Change in Walking Index for Spinal Cord Injury Version II Maximum [WISCI-II (Max)] at 2 Months of Training Phase II

Participants are scored from 0 to 20 based on the least amount of assistance/aid they require to walk a distance of 10 meters. Walking aids and physical assistance provided are ranked on an ordinal scale from 1 to 20. A score of 0 indicates the participant is unable to walk 10 m, 20 indicates no aids are required to complete the task. Results are reported as Final score - Initial score. A positive result indicates that less assistance was required.

Time frame: Change from Baseline II to 2 months of Training Phase II

Population: Measure was added to study protocol midway through study. 1 out of 18 participants did not complete this measure at this time point. Data analysed for all participants who performed this measure.

ArmMeasureValue (MEAN)Dispersion
Endurance FirstChange in Walking Index for Spinal Cord Injury Version II Maximum [WISCI-II (Max)] at 2 Months of Training Phase II0.22 units on a scaleStandard Deviation 1.33
Precision FirstChange in Walking Index for Spinal Cord Injury Version II Maximum [WISCI-II (Max)] at 2 Months of Training Phase II0.44 units on a scaleStandard Deviation 1.59
Secondary

Change in Walking Index for Spinal Cord Injury Version II Maximum [WISCI-II (Max)] at the End of 2 Months of Rest Period I

Participants are scored from 0 to 20 based on the least amount of assistance/aid they require to walk a distance of 10 meters. Walking aids and physical assistance provided are ranked on an ordinal scale from 1 to 20. A score of 0 indicates the participant is unable to walk 10 m, 20 indicates no aids are required to complete the task. Results are reported as Final score - Initial score. A positive result indicates that less assistance was required.

Time frame: Change from the end of Phase I training (measured at 2 months of Training Phase I) to 2 months of Rest Period I

Population: Measure was added to study protocol midway through study. 2 out of 17 participants did not complete this measure at this time point. Data analysed for all participants who performed this measure.

ArmMeasureValue (MEAN)Dispersion
Endurance FirstChange in Walking Index for Spinal Cord Injury Version II Maximum [WISCI-II (Max)] at the End of 2 Months of Rest Period I-0.25 units on a scaleStandard Deviation 0.53
Precision FirstChange in Walking Index for Spinal Cord Injury Version II Maximum [WISCI-II (Max)] at the End of 2 Months of Rest Period I-0.19 units on a scaleStandard Deviation 0.75
Secondary

Change in Walking Index for Spinal Cord Injury Version II Maximum [WISCI-II (Max)] at the End of 2 Months of Rest Period II

Participants are scored from 0 to 20 based on the least amount of assistance/aid they require to walk a distance of 10 meters. Walking aids and physical assistance provided are ranked on an ordinal scale from 1 to 20. A score of 0 indicates the participant is unable to walk 10 m, 20 indicates no aids are required to complete the task. Results are reported as Final score - Initial score. A positive result indicates that less assistance was required.

Time frame: Change from the end of Phase II training (measured at 2 months of Training Phase II) to 2 months of Rest Period II

ArmMeasureValue (MEAN)Dispersion
Endurance FirstChange in Walking Index for Spinal Cord Injury Version II Maximum [WISCI-II (Max)] at the End of 2 Months of Rest Period II0.00 units on a scaleStandard Deviation 0
Precision FirstChange in Walking Index for Spinal Cord Injury Version II Maximum [WISCI-II (Max)] at the End of 2 Months of Rest Period II-0.50 units on a scaleStandard Deviation 1.41
Secondary

Change in Walking Index for Spinal Cord Injury Version II Self-selected (WISCI-II ss) at 2 Months of Training Phase I

Participants are scored from 0 to 20 based on the walking aid they select to walk a distance of 10 meters. Walking aids and physical assistance provided are ranked on an ordinal scale from 1 to 20. A score of 0 indicates the participant is unable to walk 10 m, 20 indicates no aids are required to complete the task. Results are reported as Final score - Initial score. A positive result indicates that less assistance was required.

Time frame: Change from Baseline I to 2 months of Training Phase I

ArmMeasureValue (MEAN)Dispersion
Endurance FirstChange in Walking Index for Spinal Cord Injury Version II Self-selected (WISCI-II ss) at 2 Months of Training Phase I0.32 units on a scaleStandard Deviation 0.65
Precision FirstChange in Walking Index for Spinal Cord Injury Version II Self-selected (WISCI-II ss) at 2 Months of Training Phase I1.30 units on a scaleStandard Deviation 2.21
Secondary

Change in Walking Index for Spinal Cord Injury Version II Self-selected (WISCI-II ss) at 2 Months of Training Phase II

Participants are scored from 0 to 20 based on the walking aid they select to walk a distance of 10 meters. Walking aids and physical assistance provided are ranked on an ordinal scale from 1 to 20. A score of 0 indicates the participant is unable to walk 10 m, 20 indicates no aids are required to complete the task. Results are reported as Final score - Initial score. A positive result indicates that less assistance was required.

Time frame: Change from Baseline II to 2 months of Training Phase II

ArmMeasureValue (MEAN)Dispersion
Endurance FirstChange in Walking Index for Spinal Cord Injury Version II Self-selected (WISCI-II ss) at 2 Months of Training Phase II0.50 units on a scaleStandard Deviation 1.58
Precision FirstChange in Walking Index for Spinal Cord Injury Version II Self-selected (WISCI-II ss) at 2 Months of Training Phase II0 units on a scaleStandard Deviation 0
Secondary

Change in Walking Index for Spinal Cord Injury Version II Self-selected (WISCI-II ss) at the End of 2 Months of Rest Period I

Participants are scored from 0 to 20 based on the walking aid they select to walk a distance of 10 meters. Walking aids and physical assistance provided are ranked on an ordinal scale from 1 to 20. A score of 0 indicates the participant is unable to walk 10 m, 20 indicates no aids are required to complete the task. Results are reported as Final score - Initial score. A positive result indicates that less assistance was required.

Time frame: Change from the end of Phase I training (measured at 2 months of Training Phase I) to 2 months of Rest Period I

ArmMeasureValue (MEAN)Dispersion
Endurance FirstChange in Walking Index for Spinal Cord Injury Version II Self-selected (WISCI-II ss) at the End of 2 Months of Rest Period I-0.22 units on a scaleStandard Deviation 0.67
Precision FirstChange in Walking Index for Spinal Cord Injury Version II Self-selected (WISCI-II ss) at the End of 2 Months of Rest Period I-0.22 units on a scaleStandard Deviation 1.09
Secondary

Change in Walking Index for Spinal Cord Injury Version II Self-selected (WISCI-II ss) at the End of 2 Months of Rest Period II

Participants are scored from 0 to 20 based on the walking aid they select to walk a distance of 10 meters. Walking aids and physical assistance provided are ranked on an ordinal scale from 1 to 20. A score of 0 indicates the participant is unable to walk 10 m, 20 indicates no aids are required to complete the task. Results are reported as Final score - Initial score. A positive result indicates that less assistance was required.

Time frame: Change from the end of Phase II training (measured at 2 months of Training Phase II) to 2 months of Rest Period II

ArmMeasureValue (MEAN)Dispersion
Endurance FirstChange in Walking Index for Spinal Cord Injury Version II Self-selected (WISCI-II ss) at the End of 2 Months of Rest Period II0 units on a scaleStandard Deviation 0
Precision FirstChange in Walking Index for Spinal Cord Injury Version II Self-selected (WISCI-II ss) at the End of 2 Months of Rest Period II0 units on a scaleStandard Deviation 0

Source: ClinicalTrials.gov · Data processed: Mar 2, 2026